Review Article: Coffee Consumption, the Metabolic Syndrome and Non-alcoholic Fatty Liver Disease
Yesil A, Yilmaz Y
Aliment Pharmacol Ther. 2013;38:1038-1044
Coffee consumption is a part of daily life in most areas of the world. As such, a number of studies have evaluated the chemical composition and related effects that this enjoyable beverage may have on health and disease.
For many years, healthcare providers have advised patients to avoid excessive consumption because of a concern about caffeine dependence. Several recent studies, however, suggest that regular coffee consumption may modulate the risk for fibrosis in chronic liver disease.
Yesil and Yilmaz analyzed the experimental, epidemiologic, and clinical studies and the modulation of the metabolic syndrome and nonalcoholic fatty liver disease (NAFLD). Animal studies showed a reduction in the metabolic syndrome with improvements in glycemic and lipid regulation, as well as reductions in transaminases and proinflammatory cytokine hepatic gene expression. Other studies showed reductions in hepatic fat and collagen proinflammatory tumor necrosis factor, as well as increases in anti-inflammatory interleukins. Epidemiologic and clinical studies demonstrated a significant inverse association between coffee consumption and prevalence of metabolic syndrome, as well as a reduced risk for NAFLD.
Medscape Gastroenterology © 2014 WebMD, LLC
Cite this: David A. Johnson. Coffee Consumption and Chronic Liver Disease: The New Best Prescription? - Medscape - Jan 06, 2014.